A study highlights the inadequate provision of nutrition labels on US online grocery sites, calling for enhanced regulatory measures for public health.
Federal court gives Teva and Viatris another chance to invalidate J&J’s last patent for Invega Sustenna
Johnson & Johnson only has one last patent covering its long-acting blockbuster schizophrenia drug Invega Sustenna, and now Teva and Viatris have another opportunity to